 |
 |

Antichlamydial Antimicrobial Therapy for Asthma-Reply
Umit Emre, MD;
Margaret R. Hammerschlag, MD
Divisions of Pulmonology and Infectious Diseases Department of Pediatrics State University of New York Health Science Center at Brooklyn Brooklyn, NY 11203-2098
Arch Pediatr Adolesc Med. 1995;149(2):220-221.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
We appreciate Hahn's taking the time to read and comment on our recent published study in the ARCHIVES1; however, we must take exception with some of those comments. Hahn states that we found evidence of C pneumoniae infection in 21 children with reactive airway disease, including nine children who had negative cultures but had "diagnostic" antibody. Unfortunately, diagnostic antibody was also present in 37.5% of the asymptomatic controls with negative cultures, which makes the significance of this antibody questionable. We have found that antibody to C pneumoniae, as determined by the microimmunofluorescence test, is frequently not predictive of who is actually infected as determined by culture and/or polymerase chain reaction.2 There are several possible reasons for this. Unlike Chlamydia trachomatis, the major outer membrane protein does not appear to be immunodominant in C pneumoniae infection. The major outer membrane protein appears to be the primary antigen presented
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|